File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Strategies to increase the resectability of hepatocellular carcinoma

TitleStrategies to increase the resectability of hepatocellular carcinoma
Authors
KeywordsPortal vein embolization
Hepatocellular carcinoma
Portal vein ligation
Hepatectomy
Associating liver partition and portal vein ligation in staged hepatectomy
Issue Date2015
PublisherBaishideng Publishing Group. The Journal's web site is located at http://www.wjgnet.com/1948-5182/index.htm
Citation
World Journal of Hepatology, 2015, v. 7, n. 18, p. 2147-2154 How to Cite?
Abstract© 2015 Baishideng Publishing Group Inc. Hepatocellular carcinoma (HCC) is best treated by liver transplantation, but the applicability of transplantation is greatly limited. Tumor resection in partial hepatectomy is hence resorted to. However, in most parts of the world, only 20%-30% of HCCs are resectable. The main reason for such a low resectability is a future liver remnant too small to be sufficient for the patient. To allow more HCC patients to undergo curative hepatectomy, a variety of ways have been developed to increase the resectability of HCC, mainly ways to increase the future liver remnants in patients through hypertrophy. They include portal vein embolization, sequential transarterial chemoembolization and portal vein embolization, staged hepatectomy, two-staged hepatectomy with portal vein ligation, and Associating Liver Partition and Portal Vein Ligation in Staged Hepatectomy. Herein we review, describe and evaluate these different ways, ways that can be life-saving.
Persistent Identifierhttp://hdl.handle.net/10722/221385
PubMed Central ID

 

DC FieldValueLanguage
dc.contributor.authorShe, WH-
dc.contributor.authorChok, KSH-
dc.date.accessioned2015-11-18T06:09:10Z-
dc.date.available2015-11-18T06:09:10Z-
dc.date.issued2015-
dc.identifier.citationWorld Journal of Hepatology, 2015, v. 7, n. 18, p. 2147-2154-
dc.identifier.urihttp://hdl.handle.net/10722/221385-
dc.description.abstract© 2015 Baishideng Publishing Group Inc. Hepatocellular carcinoma (HCC) is best treated by liver transplantation, but the applicability of transplantation is greatly limited. Tumor resection in partial hepatectomy is hence resorted to. However, in most parts of the world, only 20%-30% of HCCs are resectable. The main reason for such a low resectability is a future liver remnant too small to be sufficient for the patient. To allow more HCC patients to undergo curative hepatectomy, a variety of ways have been developed to increase the resectability of HCC, mainly ways to increase the future liver remnants in patients through hypertrophy. They include portal vein embolization, sequential transarterial chemoembolization and portal vein embolization, staged hepatectomy, two-staged hepatectomy with portal vein ligation, and Associating Liver Partition and Portal Vein Ligation in Staged Hepatectomy. Herein we review, describe and evaluate these different ways, ways that can be life-saving.-
dc.languageeng-
dc.publisherBaishideng Publishing Group. The Journal's web site is located at http://www.wjgnet.com/1948-5182/index.htm-
dc.relation.ispartofWorld Journal of Hepatology-
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License-
dc.subjectPortal vein embolization-
dc.subjectHepatocellular carcinoma-
dc.subjectPortal vein ligation-
dc.subjectHepatectomy-
dc.subjectAssociating liver partition and portal vein ligation in staged hepatectomy-
dc.titleStrategies to increase the resectability of hepatocellular carcinoma-
dc.typeArticle-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.4254/wjh.v7.i18.2147-
dc.identifier.pmid26328026-
dc.identifier.pmcidPMC4550869-
dc.identifier.scopuseid_2-s2.0-84940366942-
dc.identifier.hkuros257272-
dc.identifier.volume7-
dc.identifier.issue18-
dc.identifier.spage2147-
dc.identifier.epage2154-
dc.identifier.eissn1948-5182-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats